Novartis Gets EU Nod for Kidney Tumor Drug Votubia

Published November 6, 2012

Novartis gets EU nod for kidney tumor drug Votubia

Filed under: drug treatment news 2012

Related Topics. Health ». ZURICH | Mon Nov 5, 2012 1:24am EST. ZURICH (Reuters) – Novartis said on Monday its drug Votubia had received approval from the European Commission for treating non-cancerous kidney tumors in patients with a rare genetic …
Read more on Reuters

BioMarin at life-high as genetic disorder drug meets main goal

Filed under: drug treatment news 2012

BioMarin, which has a market capitalization of $ 4.63 billion according to Thomson Reuters data, currently has four drugs in the market, two of which are for treating other metabolic disorders caused by the absence of certain enzymes. Shares of the …
Read more on Reuters India

Leukemia Drug Is Highly Effective MS Treatment

Filed under: drug treatment news 2012

Oct. 31, 2012 — Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment. When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduced relapse rates by …
Read more on WebMD